Related Experiment Video
Updated: May 13, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Research progress on the treatment of diabetic nephropathy with leech and its active ingredients
Feng Tian1, Xiang Yi1, Feifei Yang1
1Renal Division, Department of Medicine, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.
Insights
Hirudin, derived from leeches, shows promise in treating diabetic nephropathy (DN) by offering anti-coagulant and anti-inflammatory benefits. Further research explores its mechanisms and clinical effectiveness for kidney protection in diabetic patients.
Area of Science:
- Nephrology
- Pharmacology
- Diabetology
Background:
- Diabetic nephropathy (DN) is a leading cause of chronic kidney disease with limited treatment options.
- DN is a significant microvascular complication of diabetes, leading to poor patient prognosis.
- Hirudin, a leech-derived compound, possesses anticoagulant, anti-fibrotic, anti-thrombotic, and anti-inflammatory properties.
Purpose of the Study:
- To investigate the therapeutic potential of hirudin in managing diabetic nephropathy.
- To elucidate the mechanisms underlying hirudin's protective effects on the kidneys in DN.
- To evaluate the clinical efficacy of hirudin for DN treatment.
Main Methods:
- Review of existing literature on hirudin and diabetic nephropathy.
- Analysis of preclinical and clinical studies investigating hirudin's effects.
- Exploration of hirudin's pharmacological actions relevant to kidney protection.
Main Results:
- Hirudin demonstrates significant renoprotective effects through its multifaceted properties.
- Evidence suggests hirudin can mitigate key pathological processes in diabetic nephropathy.
- The compound's anti-inflammatory and anti-fibrotic actions are crucial for its efficacy.
Conclusions:
- Hirudin presents a promising therapeutic agent for diabetic nephropathy.
- Understanding hirudin's mechanisms can guide future treatment strategies for DN.
- Clinical evaluation is essential to confirm hirudin's efficacy and safety in DN patients.
Abstract:
Diabetic nephropathy (DN) is a major microvascular complication of diabetes and a common cause of chronic kidney disease. There is currently a lack of effective treatments for DN, and the prognosis for patients remains poor. Hirudin, one of the primary active components derived from leeches, demonstrates anti-coagulant, anti-fibrotic, anti-thrombotic, and anti-inflammatory properties, exhibiting significant protective effects on the kidneys. In recent years, there has been a surge of interest in studying the potential benefits of hirudin, especially in its role in the management of DN. This article delves into the mechanisms by which hirudin contributes to the treatment of DN and its clinical efficacy.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Related Concept Videos
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Diabetic Retinopathy
Diabetic Nephropathy
Diabetic Neuropathy